Seattle-based Sana Biotechnology announced it is selling $75M worth of its shares. The biotech company is focused on repairing and controlling genes in cells, and its treatments are aimed at cancer, diabetes and autoimmune diseases. Sana ranks as the region’s 24th-largest biotechnology employer by local employment.
Sana Biotechnology Raising $75M Through Public Offering
Share: